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ABSTRACT
Objective: Whether areas affected by Q fever during a
large outbreak (2008–2010) had higher rates of
adverse pregnancy outcomes than areas not affected
by Q fever.
Design: Nationwide registry-based ecological study.
Setting: Pregnant women in areas affected and not
affected by Q fever in the Netherlands, 2003–2004 and
2008–2010.
Participants: Index group (N=58 737): pregnant
women in 307 areas with more than two Q fever
notifications. Reference group (N=310 635): pregnant
women in 921 areas without Q fever notifications. As a
baseline, pregnant women in index and reference areas
in the years 2003–2004 were also included in the
reference group to estimate the effect of Q fever in
2008–2010, and not the already existing differences
before the outbreak.
Main outcome measures: Preterm delivery, small
for gestational age, perinatal mortality.
Results: In 2008–2010, there was no association
between residing in a Q fever-affected area and both
preterm delivery (adjusted OR 1.01 (95% CI 0.94 to
1.08)), and perinatal mortality (adjusted OR 0.87 (95%
CI 0.72 to 1.05)). In contrast, we found a weak
significant association between residing in a Q fever-
affected area in 2008–2010 and small for gestational
age (adjusted OR 1.06 (95% CI 1.01 to 1.12)), with a
population-attributable fraction of 0.70% (95% CI
0.07% to 1.34%). We observed no dose–response
relation for this outcome with increasing Q fever
notifications, and we did not find a stronger
association for women who were in their first trimester
of pregnancy during the months of high human Q
fever incidence.
Conclusions: This study found a weak association
between residing in a Q fever-affected area and the
pregnancy outcome small for gestational age. Early
detection of infection would require mass screening of
pregnant women; this does not seem to be justified
considering these results, and the uncertainties about
its efficacy and the adverse effects of antibiotic
treatment.
INTRODUCTION
Q fever, caused by Coxiella burnetii, is a world-
wide occurring zoonosis, with goats and
sheep as primary sources of human infec-
tions.1 Infected goat and sheep herds can
have high abortion rates, with massive con-
tamination of the environment from infec-
tious birth products.2 The Netherlands faced
the world’s largest reported outbreak of Q
fever, starting in 2007 and reaching a peak in
Strengths and limitations of this study
▪ The registry-based approach with nationwide
coverage of Q fever notifications and pregnancies
allowed for accurate estimation of regional differ-
ences in Q fever incidence and adverse preg-
nancy outcome.
▪ By using a multivariable model with an inter-
action term, we were able to estimate the effect
of residing in a Q fever-affected area in 2008–
2010, and not the already existing differences
before the outbreak.
▪ The classification ‘Q fever-affected area’ or ‘area
not affected by Q fever’ was based on notifica-
tions of acute Q fever. Such notification requires
a positive laboratory result indicating a recent
Coxiella burnetii infection with a matching clin-
ical presentation (fever, pneumonia or hepatitis).
Cases could be over-reported because laboratory
criteria cannot always discriminate between acute
or past resolved infection because of long-lasting
persistence of IgM antibodies and aspecific clin-
ical symptoms.
▪ The notifications of acute Q fever could also have
led to under-reporting, as people with illness
might not seek medical care or the attending
physician might not request microbiological
tests.
▪ Some misclassification might have occurred, as
people might have acquired the infection in a dif-
ferent postal code area as in which they live.
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2009.3 There are indications that the increase in acute Q
fever had already started before 2007.4
A number of case descriptions and case series reports
of pregnant women have documented that untreated
acute or chronic C. burnetii infections may result in
adverse pregnancy outcome in up to 81% of the cases.5
The risk of adverse events on the fetus is highest when
infection occurs during ﬁrst trimester.5 In addition,
reactivation of a latent C. burnetii infection might also
cause an adverse pregnancy outcome.6 These adverse
outcomes include spontaneous abortion, perinatal
death, preterm delivery, and low birth weight.5 7–11
These reports were supported by community-based
studies among pregnant women in Canada and Spain in
whom serological titres consistent with an acute or
recent Q fever infection were found to have a twofold
higher risk for poor obstetrical outcomes.6 12 However,
studies in France, the Netherlands and Denmark found
no evidence of adverse pregnancy outcome among
women with a serological indication of a C. burnetii infec-
tion.13–15 Moreover, a prospective controlled clinical trial
conducted during the outbreak in the Netherlands
showed no beneﬁts of screening for antibodies against
C. burnetii during pregnancy.16
The inconsistent ﬁndings from studies analysing the
risks of potentially serious obstetric complications and
the lack of an accurate algorithm to identify pregnancies
at risk preclude the implementation of evidence-based
preventive public health measures in case of increased
exposure. Therefore, during the Dutch outbreak,
large-scale preventive screening was not implemented.
The aim of this study was to assess whether Q fever-
affected areas had higher rates of adverse pregnancy
outcome than areas not affected by Q fever and thus, to
evaluate the policy of not implementing large-scale
screening among pregnant women during the outbreak.
METHODS
Study design and setting
This was a nationwide registry-based ecological study.
Data on Q fever incidence and pregnancy outcome were
obtained for the 3 years with the highest Q fever inci-
dence in the Netherlands (2008–2010). In addition,
data were obtained for the years 2003–2004, which pre-
ceded this large outbreak.
Defining areas affected and not affected by Q fever in
2008–2010
As in most other European countries, acute Q fever is a
notiﬁable disease in the Netherlands. For notiﬁcation,
requirements include a positive laboratory result indicat-
ing a recent C. burnetii infection and a matching clinical
presentation of fever, pneumonia or hepatitis. The
laboratory criteria were a fourfold IgG titre rise or more
measured by immunoﬂuorescence assay, ELISA or com-
plement ﬁxation test, a positive IgM phase II antibody
test or detection by PCR of C. burnetii DNA in blood or
respiratory material. These data as well as patient age,
gender, and four-digit postal-code area are recorded in
the national infectious diseases database.3
For this study, postal-code areas were divided into
those without notiﬁcations of Q fever and those with two
or more notiﬁcations (Q fever-affected areas) in one of
the outbreak years 2008–2010. Population numbers for
the year 2009 were used to calculate Q fever incidence
for Q fever-affected areas. The Q fever-affected areas
were subdivided into four quartiles: <4.59, 4.59–10.61,
10.62–21.50 and ≥21.51 notiﬁcations per 10 000 inhabi-
tants. Areas with only one notiﬁcation in a year were
excluded to minimise the risk of falsely identifying an
area as Q fever affected, as isolated infections are more
likely to have occurred outside the area of residence.
Areas not affected by Q fever were selected in two
stages. First, four-digit postal-code areas with zero Q
fever notiﬁcations in 2008 through 2010 were identiﬁed.
Then, for each Q fever-affected area, we selected three
postal-code areas not affected by Q fever (ﬁgure 1),
which resembled the affected area in their proportion
of adverse pregnancy outcomes in 2003 through 2004
(before the Q fever outbreak). With this method, we
created two area types (areas affected and not affected
by Q fever) which were comparable with respect to the
risk of obstetric complications before the start of the Q
fever outbreak.
Pregnancy outcome
Information on pregnancy outcome at the individual
level was obtained from The Netherlands Perinatal
Registry (PRN). This registry is a joint effort of the pro-
fessional organisations of midwives, gynaecologists,
obstetrically trained general practitioners and paediatri-
cians in the Netherlands. The PRN covers 96% of all
births in the Netherlands.17
Our analyses included singleton births only, from
20 weeks of gestation onwards, for which the mother’s
postal-code was known. Births of children with congeni-
tal malformations were excluded, because these malfor-
mations could lead to termination of the pregnancy.
Therefore, this could introduce bias for preterm delivery
and perinatal mortality. Additionally, a congenital mal-
formation is often accompanied with the outcome child
small for gestational age; this could also introduce bias.
We investigated three outcome variables, namely
preterm delivery, a child small for gestational age and peri-
natal mortality. Preterm delivery was deﬁned as a delivery
before a gestational age of 37 weeks. Small for gestational
age was deﬁned as a birth weight below the 10th centile, as
derived from sex-speciﬁc, parity-speciﬁc and ethnic
background-speciﬁc reference curves.18 Finally, perinatal
mortality was deﬁned as fetal (from 20 weeks of gestation
onwards) or neonatal (up to 7 days after birth).
Confounding variables
Information was collected on a number of a priori deter-
mined confounding variables known to be associated
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with both C. burnetii infection and adverse pregnancy
outcome. At the individual level, these included mater-
nal age, ethnic background and smoking behaviour.
Additionally, socioeconomic status (SES), degree of
urbanisation and animal densities (goat, sheep, and
cattle) were included at the level of the four-digit postal-
code area. Maternal age was categorised as younger than
20, 20–34 and 35 years or older.19 Ethnic background of
the mother was classiﬁed by the healthcare provider as
Western or non-Western, the latter consisting largely of
ethnic groups from Surinam, Morocco and Turkey.19
Smoking behaviour was classiﬁed by the healthcare pro-
vider as heavy (>20 cigarettes per day) and non-heavy.20
At four-digit postal-code area level, SES, degree of
urbanisation and animal densities (goat, sheep and
cattle) were included in the analysis as confounding vari-
ables. SES was estimated from the woman’s postal-code
(four-digits) using mean income level, employment and
education level.21 22 The SES was categorised as low
(≤25th centile), average (26–74th centile), and high
(≥75th centile). Degree of urbanisation was based on
information at municipality level supplied by Statistics
Netherlands and was translated to four-digit postal-code
area.23 For the year 2003, no degree of urbanisation was
available from Statistics Netherlands. We assumed that it
differed little from the following year and therefore,
applied ﬁgures for 2004 to the year 2003. Degree of
urbanisation was categorised into ﬁve categories ranging
from highly urbanised (≥2500 addresses per km2) to not
urbanised (<500 addresses per km2). As Q fever-affected
areas generally have high livestock densities, we assumed
that zoonotic infections other than Q fever might occur
in these areas. Some of the infections that can cause
adverse pregnancy outcome in humans are brucellosis,
toxoplasmosis, and infections with the bacteria
Chlamydia psittaci and Chlamydia abortus.24–28 Therefore,
as a proxy for those zoonotic infections, we considered
the animal densities as confounders. The number of
Figure 1 Postal-code areas affected by Q fever (2 or more notifications in 1 year during the years 2008, 2009 and 2010) and
postal-code areas not affected by Q fever.
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goats, sheep and cattle was based on information at
municipality level supplied by Statistics Netherlands and
was translated to four-digit postal-code area. In the
number of cattle, we excluded veal calves, because they
skewed the expected distribution of cattle. The animal
densities per square kilometre were calculated per four-
digit postal-code area and divided into three categories
of equal size for all postal-code areas in the Netherlands.
Data analysis
To investigate whether there were statistically signiﬁcant
differences in characteristics between the areas affected
and not affected by Q fever, for the periods 2003–2004
and 2008–2010, and to investigate differences for the
three pregnancy outcomes between the areas affected
and not affected by Q fever in different years, we used
the χ2 test. To determine the association between resid-
ing in a Q fever-affected area and the three adverse preg-
nancy outcomes, we performed multivariable multilevel
analyses, using the four-digit postal-code number as
cluster variable, adjusting for maternal age, ethnic back-
ground, smoking behaviour, SES, urbanisation degree,
and animal densities (goat, sheep and cattle). An inter-
action term consisting of period (before and during the Q
fever outbreak) with residing in a Q fever-affected area (yes
or no) was included in the model. The index group was
deﬁned as the pregnancy outcomes in 2008–2010 in the
areas affected by Q fever. The reference group was
deﬁned as the pregnancy outcomes in the areas not
affected by Q fever in 2008–2010 combined with out-
comes in areas affected and unaffected in the preout-
break years of 2003–2004. In our study, the interaction
term was the most important result, as we were able to
estimate only the effect of residing in a Q fever-affected
area during 2008–2010, and not the already existing dif-
ferences before the outbreak. Next, this analysis was
repeated with a Q fever incidence variable in which inci-
dence was divided into four categories to determine
whether there was a dose–response relationship. In add-
ition, we estimated for the statistically signiﬁcant associa-
tions the population-attributable fraction (PAF) with
accompanying 95% CIs,29 which represents the estimated
proportion of the adverse pregnancy outcomes that is
attributable to residing in a Q fever-affected area, if in
fact there is a causal relation. With the PAF, we esti-
mated the number of women who had a negative preg-
nancy outcome due to residing in a Q fever-affected
area in the worst-case scenario. The worst-case scenario
was based on the published estimate that one acute Q
fever notiﬁcation represents 12.6 incident infections.30
Finally, we performed a stratiﬁed analysis for women
who were in their ﬁrst trimester or in their second to
third trimester of pregnancy in April and May, the
months with highest Q fever transmission to humans.3
A p value <0.05 indicated statistical signiﬁcance. Missing
values occurred for only 1% of the outcome variable
and for all confounders. These were imputed once with
single imputation, using R software.31 32 The other
analyses were performed using SAS software V.9.3 (SAS
institute, Cary, North Carolina, USA).
RESULTS
We identiﬁed 307 postal-code areas with two or more Q
fever notiﬁcations in one of the outbreak years, and 921
areas not affected by any Q fever notiﬁcation (ﬁgure 1).
There was a statistically signiﬁcant difference in all
recorded characteristics between the areas affected and
not affected by Q fever, for the periods 2003–2004 and
2008–2010. We found the largest differences for ethnic
background, SES, urbanisation, goat density and cattle
density (table 1).
In 2003 and 2004, the proportions preterm delivery,
child small for gestational age, and perinatal mortality
were not statistically signiﬁcant different in Q fever-
affected areas compared with unaffected areas (table 2).
In 2008 and 2009, the proportion of child small for ges-
tational age was statistically signiﬁcantly higher in Q
fever-affected areas compared to unaffected areas. There
was no statistically signiﬁcant difference in preterm deliv-
ery between the areas affected and not affected by
Q fever in all years. The proportion of perinatal mortal-
ity was higher in areas not affected by Q fever except
for 2010.
The multivariable analysis conﬁrmed these results
(table 3), in which we adjusted for maternal age, ethnic
background, smoking behaviour, SES, urbanisation
degree, cattle density, goat density and sheep density.
For the pregnancy outcome child small for gestational
age, the variable residing in a Q fever-affected area had
an adjusted OR of 1.10 (95% CI 1.05 to 1.14) and the
interaction term residing in a Q fever-affected area×per-
iod had an adjusted OR of 1.06 (95% CI 1.01 to 1.12).
The ﬁrst OR of 1.10 reﬂects that the affected areas and
not affected areas already differed before the Q fever
outbreak (2003–2004). The second OR of 1.06 implies
that the differences between areas were further
increased in the period 2008–2010. This means that the
selection of the three not affected areas per affected
area was not perfect in this study. Therefore, the inter-
action term is our term of interest.
In contrast, we found no statistically signiﬁcant associ-
ation for preterm delivery and perinatal mortality in the
Q fever-affected areas in 2008–2010, compared to the
reference group.
As expected, there were stronger associated factors for
the three adverse pregnancy outcomes in the multivari-
able analyses compared to residing in a Q fever-affected
area, notably heavy smoking, young maternal age,
non-Western ethnic background of the mother, and resi-
dence in an area with low SES. The PAF for the signiﬁ-
cant relationship with the outcome child small for
gestational age was 0.70% (95% CI 0.07% to 1.34%).
This implies that—if there is a causal relation between
residing in a Q fever-affected area and adverse preg-
nancy outcome and if Q fever had not occurred—0.7%
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of the children small for gestational age in the Q fever-
affected areas could have been prevented. Accordingly,
of 5381 children small for gestational age for women res-
iding in a Q fever-affected area in 2008–2010, 38 could
have been attributable to residing in the area and in the
worst-case scenario, whereby each notiﬁed case repre-
sents 12.6 infected people, 475 could have been attribut-
able to residing in that area.
However, we found no clear dose–response relation
between a higher incidence of Q fever notiﬁcations and
all three adverse pregnancy outcomes (table 4 for the
main outcomes and see online supplementary table S1
for the detailed information).
Lastly, we found no evidence for a stronger association
between residing in a Q fever-affected area and adverse
pregnancy outcomes for women who were in their ﬁrst
trimester of pregnancy during months of high human Q
fever incidence, compared to women who were in their
second or third trimester (see online supplementary
tables 2–4).
DISCUSSION
During the years 2008–2010 of the Q fever outbreak,
pregnant women residing in a Q fever-affected area had
slightly higher rates of having children small for
Table 1 Descriptive statistics of all births in Q fever-affected areas and areas not affected by Q fever, in the years 2003










by Q fever N (%)
Maternal age (years)
<20 604 (1.4) 2561 (2.3) 767 (1.3) 2821 (1.7)
20–34 34 311 (79.8) 86 984 (78.5) 46 146 (78.1) 124 123 (77.4)
≥35 8094 (18.8) 21 231 (19.2) 12 136 (20.6) 33 474 (20.9)
Data missing 0 (0.0) 7 (<0.1) 0 (0.0) 3 (<0.1)
Ethnic background
Western 38 482 (89.5) 87 754 (79.2) 52 121 (88.3) 125 101 (78.0)
Non-Western 4247 (9.9) 22 194 (20.0) 6745 (11.4) 34 350 (21.4)
Data missing 280 (0.6) 835 (0.8) 183 (0.3) 970 (0.6)
Smoking
Heavy smokers 244 (0.6) 344 (0.3) 210 (0.4) 373 (0.2)
Non-heavy smokers 42 765 (99.4) 110 439 (99.7) 58 839 (99.6) 160 048 (99.8)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Socioeconomic status
Low 9248 (21.5) 46 882 (42.3) 15 214 (25.8) 68 886 (42.9)
Average 23 225 (54.0) 45 733 (41.3) 30 085 (50.9) 62 389 (38.9)
High 10 536 (24.5) 18 168 (16.4) 13 750 (23.3) 29 146 (18.2)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Urbanisation degree
Very high urban area 3126 (7.3) 30 643 (27.7) 4922 (8.3) 48 714 (30.4)
High urban area 7429 (17.3) 26 779 (24.2) 11 679 (19.8) 39 855 (24.8)
Moderate urban area 14 330 (33.3) 16 632 (15.0) 18 803 (31.8) 24 013 (15.0)
Minor urban area 9285 (21.6) 18 339 (16.5) 12 689 (21.5) 23 622 (14.7)
Rural area 8839 (20.5) 18 390 (16.6) 10 956 (18.6) 24 197 (15.1)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 20 (<0.1)
Goat density
Low 11 649 (27.1) 46 963 (42.4) 18 829 (31.9) 73 678 (45.9)
Medium 9577 (22.3) 39 763 (35.9) 8812 (14.9) 51 179 (31.9)
High 21 783 (50.6) 24 057 (21.7) 31 408 (53.2) 35 564 (22.2)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Sheep density
Low 17 893 (41.6) 51 111 (46.1) 28 589 (48.4) 75 135 (46.8)
Medium 17 810 (41.4) 36 943 (33.4) 20 016 (33.9) 51 945 (32.4)
High 7306 (17.0) 22 729 (20.5) 10 444 (17.7) 33 341 (20.8)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cattle density
Low 10 057 (23.4) 61 176 (55.2) 17 202 (29.1) 92 118 (57.4)
Medium 19 006 (44.2) 29 694 (26.8) 23 571 (39.9) 40 774 (25.4)
High 13 946 (32.4) 19 913 (18.0) 18 276 (31.0) 27 529 (17.2)
Data missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
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Table 2 Pregnancy outcome in Q fever-affected areas and areas not affected by Q fever
Year Area
4-Digit postal-







2003/2004 Q fever 307 42 686 6.1 10.4 0.9
No Q fever 921 109 012 6.3 10.2 1.0
2008 Q fever 307 19 735 5.9 9.2* 0.7*
No Q fever 921 52 503 6.1 8.5* 0.9*
2009 Q fever 307 19 936 5.9 9.3* 0.6*
No Q fever 921 53 221 6.1 8.6* 0.7*
2010 Q fever 307 19 066 6.3 8.9 0.7
No Q fever 921 53 213 6.0 8.5 0.7
*p<0.05.
†Preterm delivery outcome was missing for: 2003/2004 (n=2095), 2008 (n=523), 2009 (n=656) and 2010 (n=537).
‡Child small for gestational age outcome was missing for: 2003/2004 (n=1918), 2008 (n=55), 2009 (n=549) and 2010 (n=545).










Residing in a Q fever-affected
area
Yes 1.00 (0.95 to 1.05) 1.10 (1.05 to 1.14) 0.96 (0.85 to 1.09)
No Reference Reference Reference
Period 2003–2004 Reference Reference Reference
2008–2010 0.92 (0.89 to 0.95) 0.82 (0.80 to 0.84) 0.71 (0.65 to 0.77)
Interaction term: residing in a Q
fever-affected area×period†
Yes, in 2008–2010 1.01 (0.94 to 1.08) 1.06 (1.01 to 1.12) 0.87 (0.72 to 1.05)
Reference group* Reference Reference Reference
Age of the mother (years) <20 1.47 (1.34 to 1.61) 1.26 (1.17 to 1.36) 1.17 (0.91 to 1.51)
20–35 Reference Reference Reference
≥35 1.02 (0.98 to 1.06) 1.06 (1.03 to 1.09) 1.33 (1.21 to 1.45)
Ethnic background Western Reference Reference Reference
Non-Western 1.02 (0.98 to 1.06) 1.22 (1.18 to 1.26) 1.68 (1.53 to 1.85)
Smoking Heavy smoking 1.71 (1.39 to 2.09) 3.36 (2.92 to 3.87) 1.67 (0.98 to 2.84)
Non-heavy smoking Reference Reference Reference
Socioeconomic status Low 1.17 (1.11 to 1.23) 1.33 (1.27 to 1.39) 1.19 (1.05 to 1.35)
Average 1.08 (1.03 to 1.14) 1.13 (1.09 to 1.18) 1.09 (0.96 to 1.22)
High Reference Reference Reference
Urbanisation degree Very high urban area 0.94 (0.88 to 1.00) 1.05 (0.99 to 1.10) 0.89 (0.77 to 1.04)
High urban area 0.97 (0.92 to 1.03) 1.13 (1.08 to 1.19) 0.94 (0.81 to 1.08)
Moderate urban area 0.98 (0.93 to 1.04) 1.08 (1.02 to 1.13) 0.97 (0.85 to 1.12)
Minor urban area 0.92 (0.87 to 0.98) 1.01 (0.97 to 1.06) 0.86 (0.74 to 0.99)
Rural area Reference Reference Reference
Cattle density Low Reference Reference Reference
Medium 1.00 (0.95 to 1.05) 1.02 (0.98 to 1.06) 1.05 (0.93 to 1.19)
High 1.03 (0.97 to 1.10) 1.00 (0.95 to 1.05) 1.03 (0.89 to 1.20)
Goat density Low Reference Reference Reference
Medium 1.01 (0.97 to 1.05) 0.98 (0.95 to 1.02) 0.98 (0.88 to 1.09)
High 0.94 (0.89 to 0.99) 0.97 (0.93 to 1.02) 0.99 (0.88 to 1.13)
Sheep density Low Reference Reference Reference
Medium 0.97 (0.92 to 1.01) 0.95 (0.92 to 0.98) 1.00 (0.92 to 1.14)
High 0.97 (0.93 to 1.02) 0.92 (0.88 to 0.96) 1.01 (0.89 to 1.10)
Number of observations used: 312 420.
*Reference group included pregnancy outcomes in areas not affected by Q fever in 2008–2010 combined with outcomes in areas affected
and unaffected by Q fever in the preoutbreak years of 2003–2004.
†Interaction term of interest, adjusted for confounders age of the mother, ethnic background, smoking, socioeconomic status, urbanisation
degree, cattle density, goat density and sheep density.
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gestational age compared to the reference group. There
were no differences between the two groups in rates of
preterm delivery and perinatal mortality. A higher inci-
dence of Q fever notiﬁcations was not associated with
higher rates of the three adverse pregnancy outcomes.
Of the 5381 children small for gestational age of women
residing in a Q fever area in 2008–2010, 38 could have
been attributable to residing in that area. In a worst-case
scenario, this could have been 475 children. However,
this is conditional given the causal relationship between
residing in a Q fever-affected area and adverse preg-
nancy outcome, an assumption for which the present
ecological study design can provide no evidence.
Strengths and limitations
Our study has several strengths. First, the registry-based
approach with nationwide coverage of Q fever notiﬁca-
tions and pregnancies allowed for accurate estimation of
regional differences in Q fever incidence and adverse
pregnancy outcome. Second, by using a multivariable
model with an interaction term, we were able to
compare pregnancy outcomes in Q fever areas in 2008–
2010 with both the outcomes of the areas without Q
fever in 2008–2010 and the outcomes in the period
before the Q fever outbreak (in areas with and without
Q fever). Therefore, we were able to estimate the effect
of residing in a Q fever-affected area in 2008–2010, and
not the already existing differences before the outbreak.
Finally, adjustment for potential confounding variables
at the individual level was possible for those variables
that are routinely recorded in PRN.
However, our study has some limitations. First, maternal
smoking behaviour is an established risk factor for
adverse pregnancy outcome. However, as the PRN
records only heavy smoking, the role of smoking may
have been underestimated. Second, information on some
other potential confounding variables were available only
at postal-code area level. For instance, we used livestock
animal densities at a postal-code area level, as an
indicator for individual exposure to livestock animals.
Third, other well-known risk factors for an adverse preg-
nancy outcome, like body mass index, were not included
in the PRN database; therefore, we were not able to adjust
for these.33 Fourth, as the PRN registry does not contain
information on early pregnancies, we could not study
spontaneous abortion as a possible adverse outcome from
acute Q fever infection. Results from previous studies on
spontaneous abortion, as an adverse outcome from a C.
burnetii infection, are inconclusive.12 34 Fifth, there were
statistically signiﬁcant differences between areas affected
and not affected by Q fever for all characteristics in the
periods 2003–2004 and 2008–2010. However, we added
these factors to the multivariable model and therefore,
adjusted for these differences between the cohorts. Sixth,
the classiﬁcation as ‘Q fever-affected area’ or ‘area not
affected by Q fever’ was based on notiﬁcations of acute Q
fever. Such notiﬁcation requires a positive laboratory
result indicating a recent C. burnetii infection with a
matching clinical presentation (fever, pneumonia or
hepatitis). Cases could be over-reported because labora-
tory criteria cannot always discriminate between acute or
past resolved infection because of long-lasting persistence
of IgM antibodies and aspeciﬁc clinical symptoms.35 The
opposite, that is, under-reporting, applies to Q fever as
well as to many other infectious diseases, because people
with illness might not seek medical care or the attending
physician might not request microbiological tests. To
compensate for under-reporting, we performed a worst
case scenario analysis. Next, some misclassiﬁcation might
have occurred, as people might acquire the infection in a
different postal code area as in which they live. We
assumed this is the case for only a small proportion of
infected people as previous studies have shown that resi-
dential address is a good proxy for environmental expos-
ure.36 37 Lastly, any ecological study is subject to bias
when it is used to make inferences about individual
effects and is a weaker design compared with an observa-
tional study with individual data.















1.01 (0.91 to 1.11) 1.04 (0.96 to 1.13) 0.86 (0.65 to 1.14)
4.59–10.61 notifications/10 000
inhabitants, in 2008–2010
1.04 (0.92 to 1.16) 1.13 (1.03 to 1.24) 0.84 (0.62 to 1.14)
10.62–21.50 notifications/10 000
inhabitants, in 2008–2010
0.87 (0.76 to 1.00) 1.03 (0.92 to 1.15) 0.80 (0.54 to 1.19)
≥21.51 notifications/10 000
inhabitants, in 2008–2010
1.13 (0.98 to 1.31) 1.04 (0.92 to 1.16) 1.04 (0.70 to 1.57)
Reference group* Reference Reference Reference
Number of observations used: 312 420.
*Reference group included pregnancy outcomes in areas not affected by Q fever in 2008–2010 combined with outcomes in areas affected
and unaffected by Q fever in the preoutbreak years of 2003–2004.
†Adjusted for confounders age of the mother, ethnic background, smoking, socioeconomic status, urbanisation degree, cattle density, goat
density and sheep density.
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Interpretation of findings
Several case reports indicate a high risk for adverse preg-
nancy outcome after Q fever infection during preg-
nancy,5 7–11 but several large community-based studies
could not ﬁnd such a relationship.13–15 The percentage
of people with C. burnetii antibodies in the Dutch popu-
lation increased from 2.4% before the Q fever outbreak
to about 12.2% after the outbreak.38 39 Despite this very
high-attack rate, the present study found that the large
Q fever outbreak in the Netherlands posed no major
public health threat to pregnant women. However, indi-
vidual cases with an adverse pregnancy outcome, espe-
cially children small for gestational age, might have
occurred.
Early detection of infected pregnant women would
require nationwide screening, and a previous trial
showed that screening to detect acute Q fever infection
was not clinically effective.16 Given the difﬁculty of
making a consistent diagnosis of an acute infection
because of the lack of discriminating factors or even
absence of clinical factors, repeated serological screen-
ing of all pregnant women would be needed to identify
a case at risk. In addition, there are uncertainties about
the efﬁcacy and adverse effects of antibiotic treatment,
as only observational studies have been performed on
this subject. In retrospect, these ﬁndings justify the
Dutch approach of not implementing nationwide
screening during the 2007–2010 outbreak.
Conclusions and implications
We report a weak association between residing in a Q
fever-affected area and the pregnancy outcome of
having a child small for gestational age. Early detection
of infection would require mass screening of pregnant
women and this seems not to be justiﬁed based on the
results of the present study, the difﬁculty of making a
consistent diagnosis of an acute infection, the lack of dis-
criminating factors or even the absence of clinical
factors, and uncertainties about efﬁcacy and adverse
effects of antibiotic treatment. However, a case-by-case
approach, that is, early diagnosis and treatment of preg-
nant women with acute Q fever, is recommended.
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